PERCF (Percheron Therapeutics) Buyback Yield %: 0.49 (As of Jun. 27, 2026)


What is Percheron Therapeutics Buyback Yield %?

Percheron Therapeutics PERCF -0.18% Buyback Yield % is 0.49 as of Jun. 27, 2026. The stock has 2 warning signs investors should review. Among 291 Drug Manufacturers companies, Percheron Therapeutics ranks better than 78.01% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Percheron Therapeutics's current buyback yield was 0.49%.

Percheron Therapeutics Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Percheron Therapeutics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Percheron Therapeutics Buyback Yield % Chart

Percheron Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.94 -33.63 0.00 -72.39 -222.62

Percheron Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.34 -14.12 -179.61 -125.45 0.30

PERCF vs ZTS: Buyback Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Percheron Therapeutics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Percheron Therapeutics Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Percheron Therapeutics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Percheron Therapeutics's Buyback Yield % falls into.


Percheron Therapeutics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Percheron Therapeutics's Buyback Yield for the fiscal year that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-0.563 + 9.682) / 4.096203684
=-222.62%

Percheron Therapeutics's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (-0.02 + 0) / 5.119975496
=0.39%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.49 mean?
Percheron Therapeutics (PERCF) has a Buyback Yield % of 0.49 as of Jun. 27, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Percheron Therapeutics and its competitors. According to the industry distribution chart, Percheron Therapeutics ranks #64 out of 291 companies in the Drug Manufacturers industry, placing it in the top 22%.
Is Percheron Therapeutics' Buyback Yield % too high?
Percheron Therapeutics' current Buyback Yield % is 0.49. Based on the distribution chart, Percheron Therapeutics ranks #64 out of 291 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Percheron Therapeutics' Buyback Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Percheron Therapeutics ranks #64 out of 291 companies for Buyback Yield %. This places Percheron Therapeutics in the top 22% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Percheron Therapeutics and its competitors. Percheron Therapeutics's current Buyback Yield % is 0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Percheron Therapeutics stock overvalued right now?
Percheron Therapeutics (PERCF) has a current Buyback Yield % of 0.49. The current Buyback Yield % is 0.49. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Percheron Therapeutics (PERCF), the current Buyback Yield % is 0.49 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Percheron Therapeutics Business Description

Other Exchanges AWY0:GermanyPER:Australia
Address 35 Collins Street, Level 30, Collins Place, Melbourne, VIC, AUS, 3000
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.